Galderma’s Nemluvio® (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic ...
GlobalData on MSN1d
Galderma enters fierce European atopic dermatitis market with Nemluvio approval
Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...
The Pharma Letter1d
Galderma wins EU twin approvals for Nemluvio
Switzerland’s Galderma today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic ...
Galderma's Nemluvio® (Nemolizumab) Approved In The European Union For Moderate-To-Severe Atopic Dermatitis And Prurigo N...
Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now ...
Armed robbery in Revesby1d
EU Greenlights Galderma's Nemluvio for Skin Conditions
Ad hoc announcement pursuant to Art. 53 LR This approval from the European Commission is based on robust results from the phase III OLYMPIA and ...
Le Lézard1d
Valmet to start the share buy-back program for its share-based incentive plans
Valmet announced on December 18, 2024, that the Board of Directors of Valmet has decided to use the authorization granted by the Annual General Meeting held on March 21, 2024, to repurchase the ...
Le Lézard1d
Rare Cannabinoid Company Launches Sleep Month Sale on CBN Sleep Products
Rare Cannabinoid Company, a leader in hemp-derived wellness products, is celebrating February Sleep Awareness Month with an exclusive Buy One, Get One 50% Off sale on all CBN ...
dermatologyadvisor3d
The Role of IL-31 in Itch, Inflammation, and Skin Barrier Dysfunction in Prurigo Nodularis - Dermatology Advisor
PN is a chronic inflammatory skin condition characterized by intensely itchy, thickened nodules that primarily appear on the trunk and extremities. The defining feature of PN is a persistent ...
pharmaphorum1d
DiME digital measure is nocturnal scratch for atopic dermatitis
The Digital Medicine Society (DiME) is today releasing a new set of open-access resources to advance the use of nocturnal scratch in the treatment of atopic dermatitis (AD). Night-time flare-ups ...
pharmaphorum2d
It’s been a long time coming for long-term topical psoriasis treatments
Galderma adds new indication for blockbuster hope Nemluvio Galderma has claimed a second FDA approval for IL-31 inhibitor Nemluvio, adding atopic dermatitis to its label. R&D ...
Morningstar5d
Galderma Group AG Registered Shares
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Medical Xpress4d
Inflammatory disorders news
A new study published in Advanced Science has revealed how curcumin, a bioactive compound found in Curcuma aromatica (Yujin), can help mitigate neuroinflammation and brain damage caused by ...